Vincerx Pharma, Inc.
VINC
$0.809
-$0.0102-1.25%
| Weiss Ratings | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.36 | |||
| Price History | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.43% | |||
| 30-Day Total Return | -50.97% | |||
| 60-Day Total Return | -80.24% | |||
| 90-Day Total Return | -89.07% | |||
| Year to Date Total Return | -82.81% | |||
| 1-Year Total Return | -99.37% | |||
| 2-Year Total Return | -95.79% | |||
| 3-Year Total Return | -99.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -99.49% | |||
| 52-Week Low % Change | 9.23% | |||
| Price | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $160.00 | |||
| 52-Week Low Price | $0.75 | |||
| 52-Week Low Price (Date) | Mar 03, 2025 | |||
| 52-Week High Price (Date) | Mar 12, 2024 | |||
| Valuation | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.83M | |||
| Enterprise Value | -6.61M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -22.46 | |||
| Earnings Per Share Growth | -48.71% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.14 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.81 | |||
| Enterprise Value/EBITDA (TTM) | 0.24 | |||
| Enterprise Value/EBIT | 0.23 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.57M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 800 6676 | |||
| Address | 260 Sheridan Avenue Palo Alto, CA 94306 | |||
| Website | vincerx.com | |||
| Country | United States | |||
| Year Founded | 2019 | |||
| Profitability | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -85.42% | |||
| Return on Equity | -- | |||
| Income Statement | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -28.12M | |||
| EBIT (TTM) | -28.17M | |||
| Net Income (TTM) | -27.03M | |||
| Net Income Avl. to Common (TTM) | -27.03M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 12.92% | |||
| EPS Diluted (TTM) | -22.46 | |||
| EPS Diluted Growth (Q YOY) | 40.81% | |||
| Balance Sheet | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 10.09M | |||
| Cash Per Share (Q) | $6.43 | |||
| Total Current Assets (Q) | 11.75M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.11M | |||
| Current Ratio (Q) | 2.166 | |||
| Book Value Per Share (Q) | $5.80 | |||
| Total Assets (Q) | 14.95M | |||
| Total Current Liabilities (Q) | 5.42M | |||
| Total Debt (Q) | 1.64M | |||
| Total Liabilities (Q) | 5.84M | |||
| Total Common Equity (Q) | 9.11M | |||
| Cash Flow | VINC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.21M | |||
| Cash from Financing (TTM) | 17.03M | |||
| Net Change in Cash (TTM) | -12.12M | |||
| Levered Free Cash Flow (TTM) | -16.44M | |||
| Cash from Operations (TTM) | -27.97M | |||
